|
Volumn 118, Issue 1, 2001, Pages 59-67
|
Glimepiride (amaryl®): A review of its pharmacological and clinical profile
a a |
Author keywords
Amaryl; Diabetes; Glimepiride; Insulin secretion; Sulfonylurea
|
Indexed keywords
GLIMEPIRIDE;
SULFONYLUREA;
ANTIDIABETIC AGENT;
INSULIN;
SULFONYLUREA DERIVATIVE;
BINDING AFFINITY;
DRUG RECEPTOR BINDING;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
INSULIN RELEASE;
INSULIN SENSITIVITY;
JAPAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
WEIGHT GAIN;
ANIMAL;
CLINICAL TRIAL;
SECRETION;
STIMULATION;
ANIMALS;
CLINICAL TRIALS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
STIMULATION, CHEMICAL;
SULFONYLUREA COMPOUNDS;
|
EID: 0034931256
PISSN: 00155691
EISSN: None
Source Type: Journal
DOI: 10.1254/fpj.118.59 Document Type: Review |
Times cited : (6)
|
References (19)
|